MEOH vs. CC, CNQ, CVE, DVN, HAL, LYB, MUR, OVV, SM, and SU
Should you be buying Methanex stock or one of its competitors? The main competitors of Methanex include Chemours (CC), Canadian Natural Resources (CNQ), Cenovus Energy (CVE), Devon Energy (DVN), Halliburton (HAL), LyondellBasell Industries (LYB), Murphy Oil (MUR), Ovintiv (OVV), SM Energy (SM), and Suncor Energy (SU).
Methanex vs. Its Competitors
Chemours (NYSE:CC) and Methanex (NASDAQ:MEOH) are both mid-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.
In the previous week, Methanex had 7 more articles in the media than Chemours. MarketBeat recorded 12 mentions for Methanex and 5 mentions for Chemours. Chemours' average media sentiment score of 0.93 beat Methanex's score of 0.83 indicating that Chemours is being referred to more favorably in the media.
Chemours presently has a consensus target price of $17.63, indicating a potential upside of 14.49%. Methanex has a consensus target price of $45.78, indicating a potential upside of 20.11%. Given Methanex's stronger consensus rating and higher probable upside, analysts clearly believe Methanex is more favorable than Chemours.
Methanex has a net margin of 7.02% compared to Chemours' net margin of -7.19%. Chemours' return on equity of 35.14% beat Methanex's return on equity.
Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.3%. Methanex pays an annual dividend of $0.74 per share and has a dividend yield of 1.9%. Chemours pays out -12.5% of its earnings in the form of a dividend. Methanex pays out 21.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Methanex has raised its dividend for 4 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.
Chemours has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, Methanex has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500.
Methanex has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Methanex, indicating that it is currently the more affordable of the two stocks.
76.3% of Chemours shares are held by institutional investors. Comparatively, 73.5% of Methanex shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 1.0% of Methanex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
Methanex beats Chemours on 13 of the 20 factors compared between the two stocks.
Get Methanex News Delivered to You Automatically
Sign up to receive the latest news and ratings for MEOH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MEOH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Methanex Competitors List
Related Companies and Tools
This page (NASDAQ:MEOH) was last updated on 9/25/2025 by MarketBeat.com Staff